清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153–421): Design, synthesis and biochemical evaluation

可欣 化学 低密度脂蛋白受体 PCSK9 前蛋白转化酶 还原酶 他汀类 胆固醇 生物化学 低密度脂蛋白 HMG-CoA还原酶 酶 药理学 脂蛋白 生物
作者
Rasha H. Alghamdi,Paul G. O’Reilly,Chunyu Lu,James Gomes,Thomas A. Lagace,Ajoy Basak
出处
期刊:European journal of medicinal chemistry [Elsevier BV]
卷期号:92: 890-907 被引量:33
标识
DOI:10.1016/j.ejmech.2015.01.022
摘要

High level of Low Density Lipoprotein-Cholesterol (LDL-C) in circulation in the blood is associated with an elevated risk of cardiovascular disease (CVD) and stroke. Currently the statin drugs which inhibit the enzyme HMG-CoA reductase responsible for cholesterol synthesis in the liver are very effective in lowering LDL-cholesterol. However these drugs are often associated with serious side effects particularly for ∼10–12% of cases. Therefore there is a need to develop non-statin based cholesterol reducing agents. Recently it was revealed that the secreted Proprotein Convertase Subtilisin Kexin 9 (PCSK9) binds with LDL-receptor (LDL-R) causing its degradation in the lysosome with the result of LDL-C accumulating in the blood. Thus PCSK9 has become an alternative target for development of non-statin cholesterol reducing agents. It is established that the catalytic domain of PCSK9 (aa153–421) and the EGF-A domain of LDL-R (aa314–355) are involved in the above bind leading to the reduction of LDL-R level and accumulation of LDL-C. The major goal of this study is to identify peptide/s from the catalytic domain of hPCSK9 that can block the binding of hPCSK9 and LDL-R and therefore can reduce LDL-R degradation leading to the clearance of LDL-C from the plasma. Using 51 synthetic linear peptides (P1–P51) of 15aa long with 10 amino acids overlapping sequences spanning the entire catalytic segment of hPCSK9 (aa153–421), we identified two domains of hPCSK9 namely (aa323–358) and (aa365–384) that exhibited strong binding affinity towards synthetic EGF-A peptide. The results were based on mass spectrometry, fluorescence spectroscopy and native gel electrophoresis. Thus peptides containing the above segments in part (P35–P39 and P42–P47) exhibited LDL-R promoting activity when added exogenously to culture medium of growing human hepatic cells like HepG2 and HuH7. The effects were particularly significant with peptides P36, P37, P46 and P47. Interestingly, the first two peptides are present within the disulphide loop Cys323–Cys358 and contain the key gain of function mutation D374/Y site while the last two peptides contain another disulphide bridge loop Cys375–Cys378 and the second most potent gain of function mutation R357/H. Further studies revealed that S–S bridged cyclic loop peptide hPCSK9365−384 exhibited the highest (∼3.5-fold) LDL-R promoting activity in both HepG2 and HuH7 when applied at 5 μM concentration level. This effect is completely abrogated when one of the Cys residues is substituted by Ala thereby preventing any S–S bond formation. This suggested its critical role in the bioactivity. It is proposed that LDL-R promoting activity of this and other selected PCSK9 catalytic peptides such as P36, P37, P46 and P47 are most likely mediated via intervention of PCSK9:LDL-R complex formation. Our findings may find useful application in future development of small molecule PCSK9 inhibitors for intervention of hypercholesterolemia and associated cardiovascular disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
flb1227完成签到 ,获得积分10
1秒前
纤花语完成签到 ,获得积分10
2秒前
英俊的谷蓝完成签到,获得积分10
7秒前
eric_dai完成签到,获得积分10
9秒前
可靠纸飞机完成签到,获得积分10
17秒前
无辜的若枫完成签到 ,获得积分10
17秒前
21秒前
可靠的志泽完成签到 ,获得积分10
32秒前
jlwang完成签到,获得积分10
35秒前
谦让康完成签到 ,获得积分10
36秒前
文静的丹彤完成签到,获得积分10
44秒前
安静惋清完成签到,获得积分10
46秒前
eric_dai发布了新的文献求助20
55秒前
和谐的小懒虫完成签到,获得积分10
1分钟前
粗暴的镜子完成签到,获得积分10
1分钟前
开放的蚂蚁完成签到,获得积分10
1分钟前
17991完成签到,获得积分10
1分钟前
调皮烤鸡完成签到,获得积分10
1分钟前
苗苗完成签到,获得积分10
1分钟前
lishuhua完成签到 ,获得积分10
1分钟前
berry完成签到,获得积分10
1分钟前
Jasonkun完成签到,获得积分10
1分钟前
linj完成签到,获得积分10
1分钟前
虚幻百招完成签到,获得积分10
1分钟前
whitepiece完成签到,获得积分0
1分钟前
开放的乐驹完成签到 ,获得积分10
1分钟前
畅快天空完成签到,获得积分10
1分钟前
怕黑的店员完成签到,获得积分10
1分钟前
muriel完成签到,获得积分0
2分钟前
creep2020完成签到,获得积分0
2分钟前
高贵的晓啸完成签到,获得积分10
2分钟前
jlin完成签到,获得积分10
2分钟前
铜豌豆完成签到 ,获得积分10
2分钟前
冷静的尔竹完成签到,获得积分10
2分钟前
无情幻巧完成签到,获得积分10
2分钟前
珈沐完成签到,获得积分10
2分钟前
今后的应助被gyc采纳,获得10
2分钟前
e746700020完成签到,获得积分10
2分钟前
简单完成签到 ,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166425
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750507
捐赠科研通 7757226
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553507
邀请新用户注册赠送积分活动 2473845